2,4-Dichloro-6-methoxypyrimidine - CAS 43212-41-5
Catalog: |
BB025370 |
Product Name: |
2,4-Dichloro-6-methoxypyrimidine |
CAS: |
43212-41-5 |
Synonyms: |
2,4-dichloro-6-methoxypyrimidine; 2,4-dichloro-6-methoxypyrimidine |
IUPAC Name: | 2,4-dichloro-6-methoxypyrimidine |
Description: | 2,4-Dichloro-6-methoxypyrimidine (CAS# 43212-41-5) is an intermediate used to prepare piperazinyl pyrimidine derivatives as γ-secretase modulators. It is also used in the synthesis of α-azinylalkylamino-substituted (thiazolylamino)pyrimidines and -pyrazines as selective JAK2 inhibitors. |
Molecular Weight: | 179.00 |
Molecular Formula: | C5H4Cl2N2O |
Canonical SMILES: | COC1=CC(=NC(=N1)Cl)Cl |
InChI: | InChI=1S/C5H4Cl2N2O/c1-10-4-2-3(6)8-5(7)9-4/h2H,1H3 |
InChI Key: | ZSNZDRHTTWBNGI-UHFFFAOYSA-N |
MDL: | MFCD00955635 |
LogP: | 1.79200 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P264, P270, P280, P301+P312, P305+P351+P338, P330, P337+P313, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2020135507-A1 | Polysubstituted anilinopyrimidine derivative and preparation method and application thereof | 20181226 |
WO-2020064792-A1 | Heterocyclyl compounds for the treatment of autoimmune disease | 20180927 |
TW-202024065-A | Heterocyclyl compounds for the treatment of autoimmune disease | 20180927 |
EP-3856737-A1 | Heterocyclyl compounds for the treatment of autoimmune disease | 20180927 |
CA-3074719-A1 | Substituted pyrrolopyridines as atr inhibitors | 20170908 |
PMID | Publication Date | Title | Journal |
21580403 | 20100217 | 4-Chloro-2-{3-chloro-2-[(3,5-dimethyl-piperidin-1-yl)meth-yl]phenyl-sulfan-yl}-6-methoxy-pyrimidine | Acta crystallographica. Section E, Structure reports online |
21578352 | 20091017 | N-[2-Chloro-6-(4-chloro-6-methoxy-pyrimidin-2-ylsulfan-yl)benz-yl]-3,4-dimethyl-aniline | Acta crystallographica. Section E, Structure reports online |
Complexity: | 114 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 177.9700681 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 177.9700681 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 35 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.4 |
-
Catalog: BB007044
(1,10-Phenanthroline)(trifluoromethyl)copper(I)
Detail
-
Catalog: BB033560
(2,8-Bis-trifluoromethyl-quinolin-4-yl)-pyridin-2-yl-methanol
Detail
-
Catalog: BB026470
(2,4-Difluorophenylethynyl)trimethylsilane
Detail
-
Catalog: BB030493
(2,6-Difluorophenyl)thiourea
Detail
-
Catalog: BB025409
(1-Bromo-2,2,2-trifluoroethyl)benzene
Detail
-
Catalog: BB038165
(2-Chloro-5-fluoro-pyridin-3-yl)-methanol
Detail
-
Catalog: BB022403
(1,1,2,2-Tetrafluoroethoxy)benzene
Detail
-
Catalog: BB005304
(±)-Ethyl 2,3,3-trifluorobutyrate
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Pyrimidines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS